Bayer's Expert Mondays

Knowledge Sharing to Empower Your Innovation Journey

5 p.m. CET on select Mondays, July 2023 - December 2023

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health! 

Do you have that breakthrough innovation in healthcare but bringing that disruptive science to life and navigating entrepreneurial waters is a different beast?

Bayer’s mission is to boost innovation in EMEA and bring it to the patients who need it most. We are looking to enable and support standout innovation in healthcare by providing cost-free mentorship and knowledge exchange.

Join Bayer's Expert Mondays, dedicated to topics that can support you, your innovation, and your start-up in its growth! Benefit from Bayer´s global expertise, network with fellow founders and the Bayer Pharma team, and ask your questions. Let´s Collaborate to Cure!
Please note: These sessions are not intended for service providers, consultants, IT providers, etc., but are limited to drug developers and researchers in healthcare who are seeking collaboration with big pharma and out-licensing opportunities later in their journey.


Date Topic
(mouse over for full description)
Bayer Expert

July 3

5 p.m. CEST

Alternative Financing Possibilities: Creative Ways to Bridge the 'Valley of Death'

Anett Müller

BD&L Director Early Valuation

July 17

5 p.m. CEST

Medical Need: A Definition Challenge to Shape Your Value Proposition

J.P. Kruse

BD&L Senior Director 

July 31

5 p.m. CEST

Gating Decisions and How to Take the Right Ones


Dr. Hartwig Hennekes

VP, Project Management Oncology 

Sept 4

5 p.m. CEST

Spotlight on the Public/EU Grant Landscape 

Ina Kunze

BD&L Director Funding EU

Sept 18

5 p.m. CEST

Your Roadmap through the EU Regulatory Jungle

Dr. Isabelle Stoeckert

VP, Head Regulatory Affairs EMEA

Dr. Gabrielle Bräunlich

Regulatory Affairs EMEA

Sept 25

5 p.m. CEST

Venture Capital, Investment Banks: Strategic Financial Investors like Big Pharma, what are they looking for?

Vishal Patel

BD&L Strategy

Oct 9

5 p.m. CEST

Why Early Market Access Planning is a Good Investment & 10-min. deep-dive on Cell & Gene 

Bastian Haß

Market Access Lead

Franziska Gröhl

Market Access Manager

Dr. Markus Frick

Market Access Cell & Gene  

Oct 16

Nov 20

5 p.m. CEST

Building a Credible
Business Case

Anett Müller

BD&L Director Early Valuation 

Oct 23

5 p.m. CEST

Leaps by Bayer: Funding the 10 Leaps

André Guillaume

Head of Brand & Community Engagement Leaps by Bayer 

Date Topic
(mouse over for full description)
Bayer Expert

13 Nov

5 p.m. CET


Business Process of Due Diligence @ Big Pharma: Why do they need so many documents & what´s in it for you?


Dr. Anja Moews

Dr. Torsten Hertrampf

BD&L Due Diligence CoE

27 Nov

5 p.m. CET

How to Prepare a Non-Confidential Deck & Pitching Pitfalls to Avoid

Sebastian Karrer

Dr. Daniel Forler

BD&L Senior Directors

Date Topic
(mouse over for full description)
Bayer Expert

Nov 6


Munich, Germany

Panel Session

Recipes for Successful Biotech & Big Pharma Partnerships

Speakers TBA

Dec 4

5 p.m. CET

How to Build and Maintain a Successful Partnership & Bayer's Partnership Models

Dr. Christoph Huwe

Dr. Hanna Eilken

Senior Directors, Alliance Management 

Date Topic
(mouse over for full description)
Bayer Expert

Dec 11

5 p.m. CET

Bayer's Co.Labs: Incubators Around the World

Fiona Mack

VP, Head of Co.Lab Boston


About Bayer's Collaborate To Cure Hubs

The Bayer Collaborate To Cure Hub EMEA organizes these knowledge-sharing sessions to boost and support innovation in the EMEA region. As the regional hub of Bayer Pharma’s Business Development & Licensing team, we also offer a partnering interface to Bayer’s global scouting teams.

Through the Collaborate To Cure Hubs, Bayer is looking for the best and brightest ideas and projects in their respective locations for collaborations, partnerships, in-licensing, co-development, and many other forms of collaboration.

Connect with us if you are interested in collaborating, and let’s collaborate to cure to bring innovation to patients!

Bayer Collaborate To Cure Hub EMEA

Collaborate To Cure Hubs | Bayer Global


Powered by